A review of the system's log file was conducted, which confirmed that there were no malfunctions observed during the procedure.No system malfunctions were observed.A review of the device history record (dhr) for the aquabeam robotic system, lot number 19c00267, was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system, which could relate to the reported event.The review indicated that the system met all required specifications when released for distribution.A review for similar events was conducted on the aquabeam robotic system, lot number 19c00267, which confirmed that there were no other similar events reported on this system.The aquabeam system's instructions for use (ifu), ifu0101, rev.C, was reviewed and bleeding is listed as a potential perioperative risk of the aquablation procedure.The system was not returned for investigation of this complaint.Bleeding is a potential risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.
|
A male patient underwent an aquablation procedure.Per standard post-aquablation procedure, focal cauterization was performed, and the surgeon decided to administer tranexamic acid (txa) to address bleeding and the patient was transferred to the post-anesthesia care unit (pacu).The patient was later taken back to the or for persistent bleeding (per manufacturer's instructions for use, bleeding is a potential perioperative risk of the aquablation procedure).The patient presented with an arterial bleeder at the bladder neck as well as an untreated median lobe.Cauterization of the area was performed to stop the bleeding.The patient received two (2) units of blood transfusion and discharged home two (2) days post-aquablation procedure without any clinical sequela.No malfunction of the aquabeam robotic system was reported.
|